Hims & Hers Health HIMS
NYSE HIMS
$31.84 +0.75 (+2.41%)
As of: Aug 20, 2026 · 3:59 PM EDT

Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026)

Hims & Hers Health (HIMS) posted Amortization of Deferred Charges of $5.0 million for Q1 2026, up 225.91% sequentially from -$4.0 million in Q4 2025.

Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Hims & Hers Health has reported Amortization of Deferred Charges for 7 years, with the latest figure at $5.0 million in Q1 2026.

  • Quarterly Amortization of Deferred Charges changed N/A year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (up 495.56% YoY) and the FY2025 annual result came in at $4.5 million, changed N/A from the prior year.
  • Amortization of Deferred Charges improved to $5.0 million in Q1 2026 per HIMS's latest filing, from -$4.0 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $5.0 million in Q1 2026 and troughed at -$4.0 million in Q4 2025.
  • A 5-year average of $1.1 million and a median of $600000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
  • The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges changed 0.0% in 2022, then soared 512.5% in 2025.
  • Over 5 years, Amortization of Deferred Charges stood at $500000.0 in 2022, then jumped by 40.0% to $700000.0 in 2023, then increased by 14.29% to $800000.0 in 2024, then tumbled by 596.38% to -$4.0 million in 2025, then soared by 225.91% to $5.0 million in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $5.0 million, -$4.0 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Hims & Hers Health 7.42 Bn 6.57 Bn 480.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.60 Mn
Jun 30, 2026 5.60 Mn
Mar 31, 2026 5.00 Mn
Mar 31, 2026 5.00 Mn
Dec 31, 2025 -3.97 Mn
Dec 31, 2025 -3.97 Mn
Sep 30, 2025 4.90 Mn
Sep 30, 2025 4.90 Mn
Jun 30, 2025 3.60 Mn
Jun 30, 2025 3.60 Mn
Sep 30, 2024 800,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 600,000.00
Mar 31, 2024 600,000.00
Dec 31, 2023 700,000.00
Dec 31, 2023 700,000.00
Sep 30, 2023 600,000.00
Sep 30, 2023 600,000.00